Effect risk status treatment criteria Implications hypertension trials patient hypertension clinicians benefit treatment adverse effects absence interaction multiplicative model risk implies absolute benefit treatment risk adverse outcome additional risk factor absolute benefit hypertension Analyses data subgroups clinical trials hypertension treatment model valid contrast adverse effects treatment unrelated risk factors cutoff point treatment differs different individuals single treatment threshold goal entire population appropriate Patients high absolute risk prior coronary artery disease risk factors potential absolute benefit patients low threshold goal diastolic blood pressure mm Hg persons low risk white women risk factors aggressive management 